Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
€ 3.06
Key Takeaways
Risk factor
Very poor trading liquidity
Data is available to registered users only
Data is available to registered users only
Profitability factor
Greatly overvalued vs peers
Data is available to registered users only
Data is available to registered users only
About
Biogena Group Invest AG engages in the provision of dietary supplements. The company is based in Salzburg, Austria.
Company Valuation
Considering past and projected metrics, the stock is distinctly 'expensive' compared to its peers. Specifically, the stock is overvalued on EV/EBITDA.
Data is available to registered users only
Buy
Sell